Australia vs Germany: Proportion of isolates with decreased susceptibility or resistance
Australia
0.01
in 2020
Germany
0
in 2020
Australia rank
12th
Germany rank
13th
Proportion of isolates with decreased susceptibility or resistance over time
- Australia
- Germany
How they compare
Australia currently reports 0.01 against 0 in Germany, a difference of 0.01.
The two have swapped places 4 times across 10 shared years of data; in 2009 it was Australia ahead.
Australia ranks 12th and Germany ranks 13th of 52 countries.
Across the 3 decades both report, Australia averaged higher in 2 and Germany in 1.
Head to head by decade
| Decade | Australia | Germany | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0317 | 0 | 0.0317 | Australia |
| 2010s | 0.376 | 1.11 | 0.7383 | Germany |
| 2020s | 0.01 | 0 | 0.01 | Australia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Australia or Germany?
- Australia, at 0.01 against 0 in Germany as of 2020.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Australia and Germany?
- 0.01, with Australia ahead.
- How many years of comparable data are there for Australia and Germany?
- 10 years are reported by both, from 2009 to 2020.
- How do Australia and Germany rank globally for proportion of isolates with decreased susceptibility or resistance?
- Australia ranks 12th and Germany ranks 13th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.